IL82092A - Method of preparing controlled long-acting pharmaceutical formulation comprising a cellulose ether as a carrier base material - Google Patents

Method of preparing controlled long-acting pharmaceutical formulation comprising a cellulose ether as a carrier base material

Info

Publication number
IL82092A
IL82092A IL82092A IL8209287A IL82092A IL 82092 A IL82092 A IL 82092A IL 82092 A IL82092 A IL 82092A IL 8209287 A IL8209287 A IL 8209287A IL 82092 A IL82092 A IL 82092A
Authority
IL
Israel
Prior art keywords
base material
mixture
carrier base
therapeutic agent
cellulose ether
Prior art date
Application number
IL82092A
Other languages
English (en)
Other versions
IL82092A0 (en
Original Assignee
Lowey Hans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lowey Hans filed Critical Lowey Hans
Publication of IL82092A0 publication Critical patent/IL82092A0/xx
Publication of IL82092A publication Critical patent/IL82092A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL82092A 1986-04-04 1987-04-02 Method of preparing controlled long-acting pharmaceutical formulation comprising a cellulose ether as a carrier base material IL82092A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/848,702 US4775535A (en) 1986-04-04 1986-04-04 Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics

Publications (2)

Publication Number Publication Date
IL82092A0 IL82092A0 (en) 1987-10-30
IL82092A true IL82092A (en) 1990-09-17

Family

ID=25304046

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82092A IL82092A (en) 1986-04-04 1987-04-02 Method of preparing controlled long-acting pharmaceutical formulation comprising a cellulose ether as a carrier base material

Country Status (14)

Country Link
US (1) US4775535A (de)
EP (1) EP0240351B1 (de)
JP (1) JPH0751519B2 (de)
AT (1) ATE77740T1 (de)
AU (1) AU591258B2 (de)
CA (1) CA1297409C (de)
DE (1) DE3780056T2 (de)
ES (1) ES2005549A6 (de)
GR (1) GR3005851T3 (de)
IL (1) IL82092A (de)
MX (1) MX5864A (de)
PL (1) PL264984A1 (de)
YU (1) YU46312B (de)
ZA (1) ZA871818B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
IT1216570B (it) * 1988-04-08 1990-03-08 Vectorpharma Int Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
US5225201A (en) * 1991-08-23 1993-07-06 Minnesota Mining And Manufacturing Company Salsalate tablet
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
SE9301220D0 (sv) * 1993-04-14 1993-04-14 Kabi Pharmacia Ab Manufacturing matrices
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
ATE424810T1 (de) 1998-12-11 2009-03-15 Nostrum Pharmaceuticals Inc Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
US7130822B1 (en) * 2000-07-31 2006-10-31 Cognos Incorporated Budget planning
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20050112087A1 (en) * 2003-04-29 2005-05-26 Musso Gary F. Pharmaceutical formulations for sustained drug delivery
US7994220B2 (en) 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
WO2007056205A2 (en) * 2005-11-04 2007-05-18 Eastman Chemical Company Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents
KR100591142B1 (ko) * 2005-11-04 2006-06-20 지엘팜텍 주식회사 파록세틴을 활성물질로 함유하는 장용성 서방형 정제
CN103191429A (zh) * 2012-01-04 2013-07-10 韦尔斯利医药有限公司 用于缓解尿频的延长释放制剂及其使用方法
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2980589A (en) * 1958-09-12 1961-04-18 American Cyanamid Co Process for producing anhydrous granulation of a medicinally active waterlabile powder
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3388041A (en) * 1964-01-27 1968-06-11 Richardson Merrell Inc High dosage sustained release tablet
GB1171691A (en) * 1967-02-24 1969-11-26 Forest Laboratories Lond-Acting Oral Carrier
GB1279214A (en) * 1970-01-22 1972-06-28 Forest Laboratories Long-acting oral carrier
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
US3852421A (en) * 1970-03-23 1974-12-03 Shinetsu Chemical Co Excipient and shaped medicaments prepared therewith
US3957525A (en) * 1971-04-24 1976-05-18 Dunlop Limited Road surfacing materials
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
CA945899A (en) * 1971-09-16 1974-04-23 Hans Lowey Long-acting oral carrier
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
YU43437B (en) * 1976-05-05 1989-08-31 Lowey Hans Process for obtaining tablets containing an active component with long lasting effect
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4357469A (en) * 1979-06-14 1982-11-02 Forest Laboratories, Inc. Carrier base material for prolonged release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose

Also Published As

Publication number Publication date
AU591258B2 (en) 1989-11-30
US4775535A (en) 1988-10-04
DE3780056D1 (de) 1992-08-06
YU56987A (en) 1988-08-31
CA1297409C (en) 1992-03-17
ATE77740T1 (de) 1992-07-15
EP0240351B1 (de) 1992-07-01
GR3005851T3 (de) 1993-06-07
ZA871818B (en) 1987-09-02
MX5864A (es) 1994-01-31
PL264984A1 (en) 1989-03-20
JPH0751519B2 (ja) 1995-06-05
EP0240351A2 (de) 1987-10-07
DE3780056T2 (de) 1992-12-24
JPS62294626A (ja) 1987-12-22
EP0240351A3 (en) 1988-03-02
AU7099887A (en) 1987-10-08
ES2005549A6 (es) 1989-03-16
IL82092A0 (en) 1987-10-30
YU46312B (sh) 1993-05-28

Similar Documents

Publication Publication Date Title
IL82092A (en) Method of preparing controlled long-acting pharmaceutical formulation comprising a cellulose ether as a carrier base material
GB2017113B (en) Process for preparing a composition of a polymer and a physiologically active substance
HU179657B (en) Process for preparing esterasthine and pharmaceutical compositions containing such active substances
HUT37424A (en) Process for preparing new 5-pyridyl-1,3-thiazoie derivatives and pharmaceutical compositions containing thereof as active substances
HUT38652A (en) Process for preparing new ganglioside derivatives and pharmaceutical compositions containing such active substances
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
FI870588A0 (fi) Menetelmä hitaasti vapauttavan kiinteän annostusmuodon valmistamiseksi
HUT34462A (en) Process for producing oxooxazolidinyl-benzene derivatives and pharmaceutical compositions containing them as active ingredients
HUT34892A (en) Process for producing tablets with controlled dissolution of active ingredients
PT76919B (en) Process for preparing pharmaceutical mixture compositions with controlled release of active substance
PH24567A (en) Oral anti-diabetic pharmaceutical composition and the process for the preparation thereof
PT73963A (de) Verfahren zur herstellung von schnellzerfallenden arzneimittel--presslingen
DK658387A (da) Clodronat-holdige laegemidler og fremgangsmaade til fremstilling deraf
HUT46930A (en) Process for producing aminoglycoside-steroides and pharmaceutical compositions containing them as active components
EP0168360A3 (en) Process for preparing etofibrate or similar compounds containing sustained release microgranules and products thus obtained
EP0195605A3 (en) Process of making gelled cellulose triacetate product and a product made thereby
ZA848141B (en) New cyclic benzensulfonamides,process for their preparation and their use as active substance of pharmaceutical compositions
HU173308B (hu) Sposob poluchenija proizvodnykh amino-propanola i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
HUT53113A (en) Process for production of hindering tumour platina (iv) diamin komplex and medical compositions containing them as active substance
HUT34344A (en) Process for producing tablets controlled dissolution of active ingredients
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
HUT47558A (en) Process for production of 12-halogene-forscoline derivatives and medical compositions containing them as active substance
HUT51146A (en) Process for production of healing compositions containing active substances of medicinal plants
HUT34489A (en) Process for preparing 7-oxo-4-thia-1-aza-bicyclo/3,2,0/hept-2-ene derivatives and pharmaceutical compositions containing thereof as active substances
HUT47569A (en) Process for production of derivatives of perhydrotiazepin and perhydroazepin and medical compositions containing them as active substance

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
MM9K Patent not in force due to non-payment of renewal fees